POU2F2 and glioblastoma: Taken together, our results provided new insights into the biological roles of POU2F2 in pathological conditions to better understanding the underlying mechanism of glycolytic reprogramming in GBM, and identified that POU2F2 might be potential therapeutic target for GBM.